Highlights in opioid agonists and antagonists

References

• Vallerand AH. The use of long-acting opioids in chronic pain management.Nurs. Clin. North Am.38(3), 435–445 (2003).
   PubMed Web of Science ®Google Scholar
• Breivik H. Opioids in chronic non-cancer pain, indications and controversies.Eur. J. Pain9(2), 127–130 (2005).
   PubMed Web of Science ®Google Scholar
• Wollemann M, Benyhe S. Non-opioid actions of opioid peptides. Life Sci.75(3), 257–270 (2004).
   PubMedGoogle Scholar
• Lord JA, Waterfield AA, Hughes J, Kosterlitiz HW. Endogenous opioid peptides: multiple agonists and receptors. Nature267, 495–499 (1977).
   PubMed Web of Science ®Google Scholar
• Kosterlitz HW. Biosynthesis of morphine in the animal kingdom. Nature330, 606 (1987).
   PubMedGoogle Scholar
• Walker JM, Bowen WD, Walker FO et al. σ receptors: biology and function. Pharmacol. Rev.42, 355–398 (1990).
   PubMed Web of Science ®Google Scholar
• Mansour A, Khachaturian H, Lewis ME et al. Anatomy of CNS opioid receptors. Trends Neurosci.1, 308–314 (1988).
   Google Scholar
• Yamamoto T, Sakashita Y. The role of the spinal opioid receptor like 1 receptor, the NK-1 receptor, and cyclooxygenase-2 in maintaining postoperative pain in the rat. Anesth. Analg.89(5), 1203–1208 (1999).
   PubMedGoogle Scholar
• Zhang Y, Conklin DR, Li X, Eisenach JC. Intrathecal morphine reduces allodynia after peripheral nerve injury in rats via activation of a spinal A1 adenosine receptor. Anesthesiology102(2), 416–420 (2005).
   PubMedGoogle Scholar
• Stein C, Millan MJ, Yassouridis A, Herz A. Antinociceptive effects of μ and κ agonists in inflammation are enhanced by a peripheral opioid receptor-specific mechanism. Eur. J. Pharmacol.155, 255–264 (1988).
   PubMed Web of Science ®Google Scholar
• Taiwo YO, Basbaum AI, Perry F, Levine JD. Paradoxical analgesia produced by low doses of the opiate antagonist naloxone is mediated by interaction at a site with characteristics of the δ opioid receptor. J. Pharmacol. Exp. Ther. (1989) 249, 97–100.
   PubMedGoogle Scholar
• Jessell TM, Iversen LL. Opiate analgesics inhibit substance P release from rat trigeminal nucleus. Nature268, 549–551 (1977).
   PubMedGoogle Scholar
• Lembeck F. The 1988 Ulf Von Euler lecture – substance P: from extract to excitement. Acta. Physiol. Scand.13, 435–454 (1988).
   Google Scholar
• Eisenach JC, Zhang Y, Duflo F. α2-adrenoceptors inhibit the intracellular Ca2+ response to electrical stimulation in normal and injured sensory neurons, with increased inhibition of calcitonin gene-related peptide expressing neurons after injury. Neuroscience131, 189–197 (2005).
   PubMed Web of Science ®Google Scholar
• Taiwo YO, Levine JD. κ- and δ-opioids block sympathetically dependent hyperalgesia. J. Neurosci.11, 928–932 (1991).
   PubMedGoogle Scholar
• Balkowiec A, Kukula K, Szulczyk P. Influence of morphine on the activity of low-threshold visceral mechanoreceptors in cats with acute pericarditis. Pain59, 251–259 (1994).
   PubMedGoogle Scholar
• Wiesenfeld-Hallin Z. Sex differences in pain perception. Gen. Med.2(3), 137–145 (2005).
   PubMedGoogle Scholar
• Willetts J, Balster RL, Leander JD. The behavioral pharmacology of NMDA receptor antagonists. Trends Pharmacol. Sci.11, 423–428 (1990).
   Google Scholar
• Harada Y, Nishioka K, Kitahata LM et al. Contrasting actions of intrathecal U50,488H, morphine, or (D-Pen2, D-Pen5) enkephalin or intravenous U50,488H on the visceromotor response to colorectal distension in the rat. Anesthesiology83, 336–343 (1995).
   PubMed Web of Science ®Google Scholar
• Takano M, Takano Y, Yaksh TL. Release of calcitonin gene-related peptide (CGRP), substance P (SP), and vasoactive intestinal polypeptide (VIP) from rat spinal cord: modulation by α2 agonists. Peptides14, 371–378 (1993).
   PubMed Web of Science ®Google Scholar
• Schroeder JE, Fishbach PS, Zheng D, McCleskey EW. Activation of μ opioid receptors inhibits transient high- and low-threshold Ca++ currents, but spares a sustained current. Neuron6, 13–20 (1991).
   PubMedGoogle Scholar
• Kang M, Orebaugh S, Ramanathan S. The analgesic efficacy of hyperbaric subarachnoid fentanyl in parturients. Reg. Anesth.21, 82–86 (1996).
   Google Scholar
• Pasternack GW. Pharmacological mechanisms of opioid analgesics. Clin. Neuropharmacol.16, 1–18 (1993).
   PubMedGoogle Scholar
• Zhang Y, Conklin DR, Li X, Eisenach JC. Intrathecal morphine reduces allodynia after peripheral nerve injury in rats via activation of a spinal A1 adenosine receptor. Anesthesiology102(2), 416–420 (2005).
   PubMedGoogle Scholar
• Marker CL, Lujan R, Loh HH, Wickman K. Spinal G-protein-gated potassium channels contribute in a dose-dependent manner to the analgesic effect of μ- and δ- but not κ-opioids. J. Neurosci.25(14), 3551–3559 (2005).
   PubMed Web of Science ®Google Scholar
• Swenson JD, Owen J, Lamoreaux W et al. The effect of distance from injection site to the brainstem using spinal sufentanil. Reg. Anesth. Pain Med.26(4), 306–309 (2001).
   PubMedGoogle Scholar
• Gambling D, Hughes T, Martin G et al. A comparison of Depodur, a novel, single-dose extended-release epidural morphine, with standard epidural morphine for pain relief after lower abdominal surgery. Anesth. Analg.100(4), 1065–1074 (2005).
   PubMed Web of Science ®Google Scholar
• Carvalho B, Riley E, Cohen SE et al. Single-dose, sustained-release epidural morphine in the management of postoperative pain after elective cesarean delivery: results of a multicenter randomized controlled study. Anesth. Analg.100, 1150–1158 (2005).
   PubMed Web of Science ®Google Scholar
• Kimura S, Arai T. The effects of pain and systemically administered opioids on the concentration of noradrenaline (NA) and 5-hydroxyndole acetic acid (%-HIAA) in human cerebrospinal fluid. In: Proceedings of the 7th World Congress on Pain.Paris, France (1993).
   Google Scholar
• Gage HD, Gage JC, Tobin JR et al. Morphine-induced spinal cholinergic activation: in vivo imaging with positron emission tomography. Pain91(1–2), 139–145 (2001).
   PubMedGoogle Scholar
• Basbaum AI, Fields HL. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry.Ann. Rev. Neuosci.7, 309–338 (1984).
   PubMed Web of Science ®Google Scholar
• Alojado MES, Ohta Y, Yamamura T, Kemmotsu O. The effect of fentanyl and morphine on neurons in the dorsal raphe nucleus in the rat: an in vitro study.Anesth. Analg.78, 726–732 (1994).
   PubMedGoogle Scholar
• Thoburn KK, Hough LB, Nalwalk JW, Mischler AS. Histamine-induced modulation of nociceptive responses. Pain58, 29–37 (1994).
   PubMedGoogle Scholar
• Duarte ID, Ferreira SH. The molecular mechanism of central analgesia induced by morphine or carbachol and the L-arginine-nitric oxide-cGMP pathway. Eur. J. Pharmacol.221, 171–174 (1992).
   PubMed Web of Science ®Google Scholar
• Shin SW, Eisenach JC. Intrathecal morphine reduces the visceromotor response to acute uterine cervical distension in an estrogen-independent manner. Anesthesiology98(6), 1467–1471 (2003).
   PubMedGoogle Scholar
• Sandner-Kiesling A, Eisenach JC. Estrogen reduces efficacy of μ- but not κ-opioid agonist inhibition in response to uterine cervical distension. Anesthesiology96(2), 375–359 (2002).
   PubMedGoogle Scholar
• Barry U, Zuo Z. Opioids: old drugs for potential new applications. Curr. Pharm. Des.11(10), 1343–1350 (2005).
   PubMedGoogle Scholar
• Jiang X, Shi E, Nakajima Y et al. Cyclooxygenase-1 mediates the final stage of morphine-induced delayed cardioprotection in concert with cyclooxygenase-2. J. Am. Coll. Cardiol.45(10), 1707–1715 (2005).
   PubMedGoogle Scholar
• Fillingim RB, Ness TJ, Glover Tl et al. Morphine responses and experimental pain: sex differences in side effects and cardiovascular responses but not analgesia. J. Pain6(2), 116–124 (2005).
   PubMed Web of Science ®Google Scholar
• Hanna MH, Elliott KM, Fung M. Randomized, double-blind study of the analgesic efficacy of morphine-6-glucuronide versus morphine sulfate for postoperative pain in major surgery. Anesthesiology102(4), 815–821 (2005).
   PubMed Web of Science ®Google Scholar
• White JM. Pleasure into pain: the consequences of long-term opioid use. Addict Behav.29(7), 1311–1324 (2004).
   PubMed Web of Science ®Google Scholar
• Heidbreder CA, Gardner EL, Xi ZX et al. The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence. Brain Res. Rev.49(1), 77–105 (2005).
   PubMed Web of Science ®Google Scholar
• Ammon-TreiberS, Hollt V. Morphine-induced changes of gene expression in the brain. Addict. Biol.10(1), 81–89 (2005).
   PubMed Web of Science ®Google Scholar
• Maher CE, Eisenach JC, Pan HL et al. Chronic intrathecal morphine administration produces homologous μ receptor/G-protein desensitization specifically in spinal cord. Brain Res.895(1–2), 1–8 (2001).
   PubMedGoogle Scholar
• Bie B, Peng Y, Zhang Y, Pan ZZ. cAMP-mediated mechanisms for pain sensitization during opioid withdrawal. J. Neurosci.25(15), 3824–3832 (2005).
   PubMedGoogle Scholar
• Elliot K, Minami N, Kolesnikov YA et al. The NMDA receptor antagonists, LY274614 and MK-81, and the nitric oxide synthase inhibitor, ng-nitro-l-arginine, attenuate analgesic tolerance to the μ-opioid morphine but not to κ-opioids. Pain56, 69–75 (1994).
   PubMedGoogle Scholar
• Bie B, Pan ZZ. Increased glutamate synaptic transmission in the nucleus raphe magnus neurons from morphine-tolerant rats. Mol. Pain1(1), 7 (2005).
   PubMedGoogle Scholar
• Lim G, Wang S, Zeng Q et al. Evidence for a long-term influence on morphine tolerance after previous morphine exposure: role of neuronal glucocorticoid receptors. Pain114(1–2), 81–92 (2005).
   PubMed Web of Science ®Google Scholar
• Koch T, Widera A, Bartzsch K et al. Receptor endocytosis counteracts the development of opioid tolerance. Mol. Pharmacol.67(1), 280–287 (2005).
   PubMed Web of Science ®Google Scholar
• Koetzner L, Hua XY, Lai J et al. Nonopioid actions of intrathecal dynorphin evoke spinal excitatory amino acid and prostaglandin E2 release mediated by cyclooxygenase-1 and -2. J. Neurosci.24(6), 1451–1458 (2004).
   PubMedGoogle Scholar
• Wen ZH, Wu GJ, Chang YC et al. Dexamethasone modulates the development of morphine tolerance and expression of glutamate transporters in rats. Neuroscience133(3), 807–817 (2005).
   PubMed Web of Science ®Google Scholar
• Lim G, Wang S, Zeng Q et al. Spinal glucocorticoid receptors contribute to the development of morphine tolerance in rats. Anesthesiology102(4), 832–837 (2005).
   PubMed Web of Science ®Google Scholar
• Coutaux A, Adam F, Willer JC, Le Bars D. Hyperalgesia and allodynia: peripheral mechanisms. Joint Bone Spine72(5), 359–371 (2005).
   PubMed Web of Science ®Google Scholar
• Lotsch J. Pharmacokinetic-pharmacodynamic modeling of opioids.J. Pain Symptom Manage.29(Suppl. 5), 90–103 (2005).
   PubMed Web of Science ®Google Scholar
• Mystakidou K, Katsouda E, Tsilika E et al. Transdermal therapeutic fentanyl-system (TTS-F). In Vivo18(5), 633–642 (2004).
   PubMedGoogle Scholar
• Mystakidou K, Katsouda E, Parpa E et al. Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics. Am. J. Hosp. Palliat. Care22(3), 228–232 (2005).
   PubMedGoogle Scholar
• Rojas-Corrales MO, Berrocoso E, Mico JÁ. Role of 5-HT1A and 5-HT1B receptors in the antinociceptive effect of tramadol. Eur. J. Pharmacol.511(1), 21–26 (2005).
   PubMed Web of Science ®Google Scholar
• Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin. Pharmacokinet.43(13), 879–923 (2004).
   PubMed Web of Science ®Google Scholar
• Guven M, Mert T, Gunay I. Effects of tramadol on nerve action potentials in rat: comparisons with benzocaine and lidocaine. Int. J. Neurosci.115(3), 339–349 (2005).
   PubMed Web of Science ®Google Scholar
• Hara K, Minami K, Sata T. The effects of tramadol and its metabolite on glycine, γ-aminobutyric acid-A, and N-methyl-d-aspartate receptors expressed in Xenopus oocytes. Anesth. Analg.100(5), 1400–1405 (2005).
   PubMed Web of Science ®Google Scholar
• Rojas-Corrales MO, Berrocoso E, Gibert-Rahola J, Mico JÁ. Antidepressant-like effect of tramadol and its enantiomers in reserpinized mice: comparative study with desipramine, fluvoxamine, venlafaxine and opiates. J. Psychopharmacol.18(3), 404–411 (2004).
   PubMed Web of Science ®Google Scholar
• Garrett PM. Tramadol overdose and serotonin syndrome manifesting as acute right heart dysfunction. Anaesth. Intensive Care32(4), 575–577 (2004).
   PubMed Web of Science ®Google Scholar
• Hutchinson MR, Somogyi AA. (S)-(+)-methadone is more immunosuppressive than the potent analgesic (R)-(- -)-methadone. Int. Immunopharmacol.4(12), 1525–1530 (2004).
   PubMedGoogle Scholar
• Callahan RJ, Au JD, Paul M et al. Functional inhibition by methadone of N-methyl-d-aspartate receptors expressed in Xenopus oocytes: stereospecific and subunit effects. Anesth. Analg.98(3), 653–659 (2004).
   PubMed Web of Science ®Google Scholar
• Peng PW, Tumber PS, Gourlay D. Review article: perioperative pain management of patients on methadone therapy. Can. J. Anaesth.52(5), 513–523 (2005).
   PubMed Web of Science ®Google Scholar
• Ferrari A, Coccia CP, Bertolini A, Sternieri E. Methadone – metabolism, pharmacokinetics and interactions. Pharmacol. Res.50(6), 551–559 (2004).
   PubMed Web of Science ®Google Scholar
• Benmebarek M, Devaud C, Gex-Fabry M et al. Effects of grapefruit juice on the pharmacokinetics of the enantiomers of methadone. Clin. Pharmacol. Ther.76(1), 55–63 (2004).
   PubMed Web of Science ®Google Scholar
• Dale O, Sheffels P, Kharasch ED. Bioavailabilities of rectal and oral methadone in healthy subjects. Br. J. Clin. Pharmacol.58(2), 156–162 (2004).
   PubMed Web of Science ®Google Scholar
• Stewart DJ, Lambert EW, Stack KM et al. The effect of intra-articular methadone on postoperative pain following anterior cruciate ligament reconstruction. J. Bone Joint Surg. Am.87(1), 140–144 (2005).
   PubMedGoogle Scholar
• Que J, Lin LC, Liu SY et al. A novel long-acting analgesic: buprenorphine palmitate in rats. Acta Anaesthesiol. Taiwan43(1), 11–16 (2005).
   PubMedGoogle Scholar
• Umbricht A, Huestis MA, Cone EJ, Preston KL. Effects of high-dose intravenous buprenorphine in experienced opioid abusers. J. Clin. Psychopharmacol.24(5), 479–487 (2004).
   PubMed Web of Science ®Google Scholar
• Lane S, Evans P, Arfeen Z, Misra U. A comparison of intrathecal fentanyl and diamorphine as adjuncts in spinal anaesthesia for Caesarean section. Anaesthesia60(5), 453–457 (2005).
   PubMedGoogle Scholar
• Akerman N, Saxena S, Wilson R et al. Effect of intrathecal diamorphine on block height during spinal anaesthesia for Caesarean section with bupivacaine. Br. J. Anaesth.94(6), 843–847 (2005).
   PubMedGoogle Scholar
• No authors listed. Palladone for chronic pain. Med. Lett. Drugs Ther.47(1204), 21–23 (2005).
   PubMed Web of Science ®Google Scholar
• Quigley C. Hydromorphone for acute and chronic pain. Cochrane Database Syst. Rev.1, CD003447 (2002).
   Google Scholar
• Paris A, Ohlendorf C, Marquardt M et al. The effect of meperidine on thermoregulation in mice: involvement of α2-adrenoceptors. Anesth. Analg.100(1), 102–106 (2005).
   PubMedGoogle Scholar
• Zhang X, Chai LY, Tong XM et al. Mechanisms of pethidine-induced vasodilatation. Zhejiang Da Xue Xue Bao Yi Xue Ban33(2), 166–169 (2004).
   PubMedGoogle Scholar
• Wolff M, Olschewski A, Vogel W, Hempelmann G. Meperidine suppresses the excitability of spinal dorsal horn neurons. Anesthesiology100(4), 947–955 (2004).
   PubMedGoogle Scholar
• Shimizu M, Inai K, Nakazawa M. The use of pethidine as pre-medication to prevent anoxic spells in patients with tetralogy of Fallot. Pediatr. Int.47(4), 388–391 (2005).
   PubMedGoogle Scholar
• Nelson KE, Eisenach JC. Intravenous butorphanol, meperidine, and their combination relieve pain and distress in women in labor. Anesthesiology102(5), 1008–1013 (2005).
   PubMedGoogle Scholar
• Mavioglu O, Ozkardesler S, Tasdogen A et al. Effect of analgesia administration timing on early post-operative period characteristics: a randomized, double-blind, controlled study. J. Int. Med. Res.33(5), 483–489 (2005).
   PubMed Web of Science ®Google Scholar
• Seifert CF, Kennedy S. Meperidine is alive and well in the new millennium: evaluation of meperidine usage patterns and frequency of adverse drug reactions. Pharmacotherapy24(6), 776–783 (2004).
   PubMedGoogle Scholar
• Evron S, Glezerman M, Sadan O et al. Remifentanil: a novel systemic analgesic for labor pain. Anesth. Analg.100(1), 233–238 (2005).
   PubMedGoogle Scholar
• Van Aken H, Kick O, Weissauer W. Obstetric peridural anesthesia with sufentanil. Is it contraindicated? Anaesthesist43(10), 667–670 (1994).
   PubMedGoogle Scholar
• Hansdottir V, Hedner T, Woestenborghs R, Nordberg G. The CSF and plasma pharmacokinetics of sufentanil after intrathecal administration. Anesthesiology74(2), 264–269 (1991).
   PubMed Web of Science ®Google Scholar
• Nordberg G, Hedner T, Mellstrand T, Dahlstrom B. Pharmacokinetic aspects of intrathecal morphine analgesia. Anesthesiology60(5), 448–454 (1984).
   PubMed Web of Science ®Google Scholar
• Fournier R, Weber A, Gamulin Z. Intrathecal sufentanil is more potent than intravenous for postoperative analgesia after total-hip replacement. Reg. Anesth. Pain Med.30(3), 249–254 (2005).
   PubMedGoogle Scholar
• Tamanai-ShacooriZ, Shacoori V, Vo Van JM et al. Sufentanil modifies the antibacterial activity of bupivacaine and ropivacaine. Can. J. Anaesth.51(9), 911–914 (2004).
   PubMed Web of Science ®Google Scholar
• Lauretti GR, Oliveira GM, Pereira NL. Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients. Br. J. Cancer89(11), 2027–2030 (2003).
   PubMed Web of Science ®Google Scholar
• Chindalore VL, Craven RA, Yu KP et al. Adding ultralow-dose naltrexone to oxycodone enhances and prolongs analgesia: a randomized, controlled trial of oxytrex. J. Pain6(6), 392–399 (2005).
   PubMed Web of Science ®Google Scholar
• Yanagidate F, Dohi S. Epidural oxycodone or morphine following gynaecological surgery. Br. J. Anaesth.93(3), 362–367 (2004).
   PubMed Web of Science ®Google Scholar
• Levine B, Moore KA, Aronica-Pollak P, Fowler DF. Oxycodone intoxication in an infant: accidental or intentional exposure? J. Forensic Sci.49(6), 1358–1360 (2004).
   PubMed Web of Science ®Google Scholar
• Petrakis IL, Poling J, Levinson C et al. Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders. Biol. Psychiatry57(10), 1128–1137 (2005).
   PubMed Web of Science ®Google Scholar
• Koppert W, Filitz J, Troster A et al. Activation of naloxone-sensitive and -insensitive inhibitory systems in a human pain model. J. Pain6(11), 757–764 (2005).
   PubMedGoogle Scholar
• Xiang H, Tian Y, Sun Y. Effect of morphine and naloxone on release of the excitatory amino acids of spinal astrocytes induced by TNF-α. J. Huazhong Univ. Sci. Technol. Med. Sci.25(1), 91–93 (2005).
   PubMedGoogle Scholar
• Cantwell K, Dietze P, Flander L. The relationship between naloxone dose and key patient variables in the treatment of non-fatal heroin overdose in the prehospital setting. Resuscitation65(3), 315–319 (2005).
   PubMed Web of Science ®Google Scholar
• Atcheson R, Lambert DG. Update on opioid receptors. Br. J. Anaesth.24, 132–134 (1994).
   Google Scholar
• Fuller JG, McMorland GH, Douglas MJ, Palmer L. Epidural morphine for analgesia after caesarean section: a report of 4880 patients. Can. J. Anaesth.37, 636–640 (1990).
   PubMed Web of Science ®Google Scholar
• LaBella FS, Kim RS, Templeton J. Opiate receptor binding activity of 17-α estrogenic steroids. Life Sci.23, 1797–1804 (1978).
   PubMedGoogle Scholar
• Chaney MA. Side effects of intrathecal and epidural opioids. Can. J. Anaesth.42, 891–903 (1995).
   PubMed Web of Science ®Google Scholar
• Harris AL. Citotoxic-therapy-induced vomiting is mediated via enkephalin pathways (hypothesis). Lancet1, 714–716 (1982).
   PubMed Web of Science ®Google Scholar
• Stenseth R, Sellevold O, Breivik H. Epidural morphine for postoperative pain: experience with 1085 patients. Acta Anaesthesiol. Scand.29, 148–156 (1985).
   PubMed Web of Science ®Google Scholar
• Loper KA, Ready LB, Dorman BH. Prophylactic transdermal scopolamine patches reduce nausea in postoperative patients receiving epidural morphine. Anesth. Analg.68, 144–146 (1989).
   PubMedGoogle Scholar
• Wattwil M. Postoperative pain relief and gastrointestinal motility. Acta Chir. Scand.550, 140–145 (1988).
   Google Scholar
• Morgan M. The rational use of intrathecal and extradural opioids. Br. J. Anaesth.63, 165–188 (1989).
   PubMed Web of Science ®Google Scholar
• Rawal N, Möllefors K, Axelsson K et al. An experimental study of urodynamic effects of epidural morphine and of naloxone reversal. Anesth. Analg.62, 641–647 (1983).
   PubMed Web of Science ®Google Scholar
• Koren G, Sandler NA, Klein J et al. Relationship between the pharmacokinetics and the analgesic and respiratory pharmacodynamics of epidural sufentanil. Clin. Pharmacol. Ther.46, 458–462 (1989).
   PubMedGoogle Scholar
• Shook JE, Watkins WD, Cxamporesi EM. Differential roles of opioid receptors in respiration, respiratory disease, and opiate-induced respiratory depression. Am. Rev. Respir. Dis.142, 895–909 (1990).
   PubMed Web of Science ®Google Scholar
• Houghton IT, Aun CST, Wong YC et al. The respiratory depressant effect of morphine. A comparative study in three ethnic groups. Anaesthesia49, 197–201 (1994).
   PubMedGoogle Scholar
• Bailey PL, Rhondeau S, Schafer PG et al. Dose-response pharmacology of intrathecal morphine in human volunteers. Anesthesiology79, 49–59 (1993).
   PubMed Web of Science ®Google Scholar
• Shulman MS, Sandler A, Bredner J. The reversal of epidural morphine induced somnolence with physostigmine. Can. Anaesth. Soc.31, 678–681 (1984).
   PubMedGoogle Scholar
• Bowdle TA, Rooke GA. Postoperative myoclonus and rigidity after anesthesia with opioids. Anesth. Analg.78, 783–786 (1994).
   PubMedGoogle Scholar
• Landow L. An apparent seizure following inadvertent intrathecal morphine. Anesthesiology62, 545–546 (1985).
   PubMedGoogle Scholar
• Borgeat A, Biollaz J, Depierras B, Neff R. Grand mal seizure after extradural morphine analgesia. Br. J. Anaesth.60, 733–735 (1988).
   PubMedGoogle Scholar
• Lauretti GR, Ahmad I, Pleuvry BJ. The activity of opioid analgesics in seizure models utilising N-methyl-dl-aspartic acid, kainic acid, bicuculline and pentylenetetrazole. Neuropharmacology33, 155–160 (1994).
   PubMedGoogle Scholar
• Woolf CJ. Intrathecal high dose morphine produces hyperalgesia in the rat. Brain Res.209, 491–495 (1981).
   PubMed Web of Science ®Google Scholar
• Sjöberg M, Nitescu P, Appelgren L, Curelaru I. Long-term intrathecal morphine and bupivacaine in patients with refractory cancer pain. Anesthesiology80, 294–297 (1994).
   Google Scholar
• Bayer BM, Daussin S, Hernandez M et al. Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism. Neuropharmacology29, 369–374 (1990).
   PubMedGoogle Scholar
• Pruett SB, Han YC, Fuchs BA. Morphine suppresses primary humoral immune responses by a predominantly indirect mechanism. J. Pharmacol. Exp. Ther.262, 923–928 (1992).
   PubMed Web of Science ®Google Scholar
• Mercadante S, Ferrera P, Villari P, Arcuri E. Hyperalgesia: an emerging iatrogenic syndrome. J. Pain Symptom Manage.26(2), 769–775 (2003).
   PubMed Web of Science ®Google Scholar
• Koppert W, Angst M, Alsheimer M et al. Naloxone provokes similar pain facilitation as observed after short-term infusion of remifentanil in humans. Pain106(1–2), 91–99 (2003).
   PubMed Web of Science ®Google Scholar
• Ruscheweyh R, Sandkuhler J. Opioids and central sensitisation: II. Induction and reversal of hyperalgesia. Eur. J. Pain9(2), 149–152 (2005).
   PubMed Web of Science ®Google Scholar
• Porreca F, Filla A, Burks TF. Spinal cord mediated opiate effects on gastrointestinal transit in mice. Eur. J. Pharmacol.86, 135–136 (1983).
   Google Scholar
• Oltmanns KM, Fehm HL, Peters A. Chronic fentanyl application induces adrenocortical insufficiency. J. Intern. Med.257(5), 478–480 (2005).
   PubMed Web of Science ®Google Scholar
• No authors listed. Torsades de pointes with methadone. Prescrire. Int.14(76), 61–62 (2005).
   PubMedGoogle Scholar
• Boyle J. Medical ethics and double effect: the case of terminal sedation. Theor. Med. Bioeth.25(1), 51–60 (2004).
   PubMed Web of Science ®Google Scholar
• Maxwell JC, Pullum TW, Tannert K. Deaths of clients in methadone treatment in Texas: 1994–2002. Drug Alcohol Depend.78(1), 73–81 (2005).
   PubMed Web of Science ®Google Scholar
• Wolf BC, Lavezzi WA, Sullivan LM, Flannagan LM. One hundred seventy two deaths involving the use of oxycodone in Palm Beach County. J. Forensic Sci.50(1), 192–195 (2005).
   PubMedGoogle Scholar
• Nekhayeva IA, Nanovskaya TN, Deshmukh SV et al. Bidirectional transfer of methadone across human placenta. Biochem. Pharmacol.69(1), 187–197 (2005).
   PubMed Web of Science ®Google Scholar